NLM Logo

LSA2-L2 protocol MeSH Supplementary Concept Data 2024


MeSH Supplementary
LSA2-L2 protocol
Unique ID
C036202
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C036202
Entry Term(s)
LSA(2)-L(2)
LSA2 L2
LSA2-L2
Registry Number
0
Heading Mapped to
*Antineoplastic Combined Chemotherapy Protocols
Cyclophosphamide
Daunorubicin
Methotrexate
Prednisone
Vincristine
Frequency
50
Note
chemotherapy protocol consisting of above 5 cpds plus consolidation with or without other modifications
Source
Blood 1982;60(5):1159
Date of Entry
1982/11/26
Revision Date
2020/09/30
LSA2-L2 protocol Preferred
page delivered in 0.004s